EGFR and lung cancer: For example, if the lung cancer cell line PC9 was exposed to an EGFR inhibitor, a subset of the typically susceptible cells developed resistance by adopting a seemingly reversible epigenetic state, which could be mitigated by the administration of a histone deacetylase inhibitor[65].